Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 3Recurrence 2Ovarian Neoplasms 2Neoplasms 2Hypersensitivity 2Neoplasm Metastasis 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1Brain Neoplasms 1

Interventions

olaparib 7Carboplatin 2pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fanconi Anemia, Complementation Group D1 × iniparib × Clear all
NCT00677079 2013-10-01

Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sanofi

Phase 2 Completed
12 enrolled
Classical hematology

Fanconi Anemia, Complementation Group D1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡